Xiufang Mi
Chinese Academy of Sciences(CN)Zhejiang Cancer Hospital(CN)Shaanxi Provincial Hospital of Traditional Chinese Medicine(CN)Hangzhou Cancer Hospital(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Asthma and respiratory diseases, Nanoparticle-Based Drug Delivery, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Pharmacist-led standardization of total parenteral nutrition improves postoperative nutritional status in colorectal cancer patients(2022)10 cited
- → Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study(2024)8 cited
- → Cost-effectiveness of PARP inhibitors in malignancies: A systematic review(2022)5 cited
- → Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer(2024)2 cited
- → Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence(2025)1 cited
- → Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China(2024)1 cited